Shares Magazine
6.40p+0.20 (+3.23%)20 Dec 2024, 16:35
Jump to:
Allergy Therapeutics PLC Fundamentals
| Company Name | Allergy Therapeutics PLC | Last Updated | 2024-12-20 |
|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Sector | Healthcare |
| Shares in Issue | 4.766 bn | Market Cap | £305.05 m |
| PE Ratio | 49.50 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.01 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.4780 | Debt Equity Ratio | 7.7843 |
| Asset Equity Ratio | 17.4783 | Cash Equity Ratio | 3.4281 |
| Quick Ratio | 0.9735 | Current Ratio | 1.63 |
| Price To Book Value | 81.9672 | ROCE | 0 |
Allergy Therapeutics PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Allergy Therapeutics PLC Company Financials
| Assets | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tangible Assets | £23.75 m | £23.24 m | £20.19 m | £19.72 m |
| Intangible Assets | £4.69 m | £5.14 m | £5.04 m | £4.75 m |
| Investments | 0 | 0 | 0 | 0 |
| Total Fixed Assets | £31.34 m | £33.24 m | £30.55 m | £30.23 m |
| Stocks | £12.74 m | £11.59 m | £11.41 m | £10.84 m |
| Debtors | £7.29 m | £6.55 m | £9.21 m | £5.78 m |
| Cash & Equivalents | £12.71 m | £14.64 m | £20.32 m | £40.07 m |
| Other Assets | 0 | 0 | 0 | 0 |
| Total Assets | £64.83 m | £66.77 m | £72.95 m | £88.09 m |
| Liabilities | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Creditors within 1 year | £20.55 m | £18.57 m | £18.05 m | £18.23 m |
| Creditors after 1 year | £40.57 m | £46.14 m | £17.13 m | £21.32 m |
| Other Liabilities | 0 | 0 | 0 | 0 |
| Total Liabilities | £61.12 m | £64.70 m | £35.18 m | £39.55 m |
| Net assets | £3.71 m | £2.07 m | £37.77 m | £48.53 m |
| Equity | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Called up share capital | £4.77 m | £679,000.00 | £644,000.00 | £641,000.00 |
| Share Premium | £154.64 m | £119.03 m | £112.58 m | £112.58 m |
| Profit / Loss | -£39.17 m | -£41.77 m | -£12.66 m | £3.66 m |
| Other Equity | £3.71 m | £2.07 m | £37.77 m | £48.53 m |
| Preference & Minorities | 0 | 0 | 0 | 0 |
| Total Capital Employed | £3.71 m | £2.07 m | £37.77 m | £48.53 m |
| Ratios | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Debt Ratio | £0.89 | £0.94 | £0.18 | £0.16 |
| Debt-to-Equity | £7.78 | £16.55 | £0.22 | £0.19 |
| Assets / Equity | 17.4783 | 17.4783 | 17.4783 | 17.4783 |
| Cash / Equity | 3.4281 | 3.4281 | 3.4281 | 3.4281 |
| EPS | -£0.01 | -£0.06 | -£0.02 | £0.00 |
| Cash Flow | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Cash from operating activities | -£32.14 m | -£28.88 m | -£14.00 m | £8.59 m |
| Cashflow before financing | -£707,000.00 | -£1.08 m | -£16.81 m | £6.37 m |
| Increase in Cash | -£1.91 m | -£5.67 m | -£19.80 m | £3.73 m |
| Income | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Turnover | £55.20 m | £59.59 m | £72.77 m | £84.33 m |
| Cost of sales | £25.46 m | £26.34 m | £23.26 m | £22.11 m |
| Gross Profit | £29.74 m | £33.24 m | £49.51 m | £62.23 m |
| Operating Profit | -£35.26 m | -£39.65 m | -£12.24 m | £4.03 m |
| Pre-Tax profit | -£39.17 m | -£41.77 m | -£12.66 m | £3.66 m |
Allergy Therapeutics PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany, Austria, Netherlands, and Switzerland. |
| Latest Interim Date | 27 Mar 2024 |
| Latest Fiscal Year End Date | 6 Nov 2024 |
Allergy Therapeutics PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-11-21 | Dr. Babatunde Adekunle Otulana | Non-Executive Director,Senior Independent Director |
| 2024-11-21 | Mr. Peter Sinclair Jensen | Non-Executive Director,Chairman |
| 2014-10-08 | Mr. Alejandro Esteban Manieu Weinstein Jr | Non-Executive Director |
| 2011-10-21 | Dr. Thomas Alexander Hungerford Holdich | Executive Director,RandD Director |
| 2011-10-21 | Dr. Christian Gratz | Executive Director,Market Operations Director |
| 2016-09-26 | Mr. Ian David Postlethwaite | Executive Director,Finance Director and Company Secretary |
| 2012-06-29 | Ms. Ignace Robert Agnes Goethals | Non-Executive Director |
| 2021-11-22 | Mr. Stephen Rushworth Smith | Non-Executive Director,Senior Independent Director |
| 2024-11-21 | Mr. Manuel Llobet | Executive Director,Chief Executive Officer |
| 2012-06-29 | Dr. Virinder Nohria | Non-Executive Director |
| 2011-10-21 | Mr. Keith Iain Carter | Non-Executive Director |
| 2022-05-26 | Mr. Nicolas Alexander Ulrich Wykeman | Executive Director,Chief Financial Officer |
| 2024-11-21 | Mr. Zheqing Shen | Non-Executive Director |
| 2024-11-21 | Mr. Anthony Michael Parker | Non-Executive Director |
| 2024-11-21 | Mr. Shaun Furlong | Executive Director,Chief Financial Officer |
Allergy Therapeutics PLC Contact Details
| Company Name | Allergy Therapeutics PLC |
|---|---|
| Address | Dominion Way, Worthing, BN14 8SA |
| Telephone | +44 1903844700 |
| Website | https://www.allergytherapeutics.com |
Allergy Therapeutics PLC Advisors
| Financial PR Adviser | Consilium Strategic Communications |
|---|---|
| Phone | +44 2037095700 |
| Solicitor | Cooley LLP |
|---|---|
| Phone | +44 2075834055 |
| Fax | +44 2077859355 |
| Nominated Adviser | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
| Stockbroker | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 8716640300 |
| Fax | +44 2086392342 |
| Solicitor | Covington & Burling LLP |
|---|---|
| Phone | +44 2070672000 |
| Fax | +44 2070672222 |
| Auditor | Grant Thornton UK LLP |
|---|---|
| Phone | +44 1293554130 |
| Fax | +44 1293554135 |
| Bank | Royal Bank of Scotland PLC |
|---|
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Raspberry Pi Holdings PLC | 588.00 | 15.75 |
| Bakkavor Group PLC | 146.50 | 5.40 |
| Harworth Group PLC | 166.50 | 3.74 |
| Metro Bank Holdings PLC | 99.90 | 3.63 |
| Carnival PLC | 1,887.00 | 3.62 |
| Harbourvest Global Private Equity Limited | 2,585.00 | 3.61 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Puretech Health PLC | 154.60 | -3.25 |
| Close Brothers Group PLC | 223.00 | -3.21 |
| European Opportunities Trust PLC | 770.00 | -3.14 |
| Games Workshop Group PLC | 13,000.00 | -2.99 |
| Pz Cussons PLC | 80.00 | -2.56 |
| Severn Trent PLC | 2,516.00 | -2.25 |
Risers/fallers data from previous trading day.